tradingkey.logo

Codexis Inc

CDXS
2.035USD
-0.115-5.35%
Cierre 11/06, 16:00ETCotizaciones retrasadas 15 min
183.67MCap. mercado
PérdidaP/E TTM

Más Datos de Codexis Inc Compañía

Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Información de Codexis Inc

Símbolo de cotizaciónCDXS
Nombre de la empresaCodexis Inc
Fecha de salida a bolsaApr 22, 2010
Director ejecutivoDr. Stephen G. Dilly, Ph.D.
Número de empleados188
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 22
Dirección200 Penobscot Dr
CiudadREDWOOD CITY
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94063
Teléfono16504218100
Sitio Webhttps://www.codexis.com/
Símbolo de cotizaciónCDXS
Fecha de salida a bolsaApr 22, 2010
Director ejecutivoDr. Stephen G. Dilly, Ph.D.

Ejecutivos de Codexis Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
Executive Vice President, Chief Technical Officer
Executive Vice President, Chief Technical Officer
92.46K
-6.32%
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
88.83K
+85.66%
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
+92.83%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
70.64K
-8.12%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
+26.74%
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+10.73%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
147.90K
+38.33%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
132.05K
+45.00%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
+46.54%
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
+57.58%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
APAC
6.58M
42.93%
America
6.35M
41.44%
EMEA
2.40M
15.63%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Opaleye Management Inc.
13.97%
Casdin Capital, LLC
7.98%
BlackRock Institutional Trust Company, N.A.
6.48%
The Vanguard Group, Inc.
5.08%
Fidelity Management & Research Company LLC
4.82%
Otro
61.67%
Accionistas
Accionistas
Proporción
Opaleye Management Inc.
13.97%
Casdin Capital, LLC
7.98%
BlackRock Institutional Trust Company, N.A.
6.48%
The Vanguard Group, Inc.
5.08%
Fidelity Management & Research Company LLC
4.82%
Otro
61.67%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
28.84%
Hedge Fund
28.38%
Investment Advisor/Hedge Fund
19.18%
Individual Investor
2.59%
Research Firm
1.18%
Pension Fund
0.20%
Bank and Trust
0.18%
Venture Capital
0.05%
Insurance Company
0.03%
Otro
19.36%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
257
69.82M
77.34%
-3.13M
2025Q2
284
75.27M
90.86%
-6.81M
2025Q1
321
69.35M
83.91%
-9.24M
2024Q4
334
67.97M
82.44%
-9.17M
2024Q3
341
66.67M
93.65%
-3.04M
2024Q2
355
56.24M
79.41%
-16.85M
2024Q1
368
57.66M
81.73%
-20.93M
2023Q4
384
58.98M
84.48%
-18.95M
2023Q3
392
59.46M
85.28%
-19.41M
2023Q2
387
64.66M
96.86%
-12.85M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Opaleye Management Inc.
12.61M
13.97%
+10.00K
+0.08%
Jul 30, 2025
Casdin Capital, LLC
7.20M
7.98%
-900.00K
-11.11%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.85M
6.48%
-376.85K
-6.05%
Jun 30, 2025
The Vanguard Group, Inc.
4.59M
5.08%
-135.73K
-2.87%
Jun 30, 2025
Fidelity Management & Research Company LLC
4.35M
4.82%
+40.93K
+0.95%
Jun 30, 2025
abrdn Inc.
4.20M
4.65%
+3.59M
+592.89%
Jun 30, 2025
Nantahala Capital Management, LLC
4.03M
4.47%
+1.20M
+42.39%
Jun 30, 2025
Telemark Asset Management, LLC
4.00M
4.43%
+1.00M
+33.33%
Jun 30, 2025
Columbia Threadneedle Investments (US)
2.55M
2.83%
+16.10K
+0.64%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.98M
2.19%
+52.59K
+2.73%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.19%
iShares Micro-Cap ETF
0.04%
Fidelity Enhanced Small Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
Global X Russell 2000 ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.43%
Inspire Small/Mid Cap ESG ETF
Proporción0.19%
iShares Micro-Cap ETF
Proporción0.04%
Fidelity Enhanced Small Cap ETF
Proporción0.03%
Invesco Nasdaq Biotechnology ETF
Proporción0.02%
iShares Biotechnology ETF
Proporción0.02%
ProShares Ultra Nasdaq Biotechnology
Proporción0.02%
Global X Russell 2000 ETF
Proporción0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI